Stay updated on Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.

Latest updates to the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedRecruitment status now shows 'No longer looking for participants'. New navigation/help items have been added (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment header has been standardized from 'Intervention / Treatment', and the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check15 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, reflecting a minor version update to the page template without altering study details or results content.SummaryDifference0.0%

- Check29 days agoChange DetectedNo changes are listed for this page in the provided data.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4. This indicates a new release or patch level was applied.SummaryDifference0.1%

- Check50 days agoChange DetectedA new publication citation was added to the Publications section, referencing a 2026 Nat Commun article on spatial predictors of response to chemo-immunotherapy in MSS metastatic colorectal cancer. This update broadens the scholarly context available for the MAYA study.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s displayed software revision/version changed from v3.5.2 to v3.5.3, reflecting an update to the site template or backend release rather than the underlying study details.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.